Targeted therapy plays an antitumor role by combining drugs with related carcinogenic targets, such as epidermal growth factor receptor (EGFR), vascular epidermal growth factor (VEGF) and its receptor (VEGFR), etc. When targeted drugs combine with these targets, tumor proliferation and angiogenesis can be inhibited. This evidence concerns the gene VEGFA and neoplasm.